Related Experiment Video
Updated: Aug 10, 2026
11:01
Ferromagnetic Bare Metal Stent for Endothelial Cell Capture and Retention
Published on: September 18, 2015
[Metallic biomaterials for coronary stents]
A Fischer1, H Wieneke, H Brauer
1Universität Essen Werkstofftechnik Universitätsstr. 15 45117 Essen, Germany.
Zeitschrift Fur Kardiologie
|May 31, 2001
Summary
Coronary stents improved angioplasty, but restenosis persists. Stent material significantly impacts neointima formation and restenosis rates, necessitating further research into biocompatible alloys.
Area of Science:
- Interventional Cardiology
- Biomaterials Science
- Cardiovascular Research
Context:
- Coronary stenting has revolutionized cardiology since its inception in 1986.
- While effective, restenosis (re-narrowing of the artery) remains a significant limitation.
- The medical implant itself, the stent, is increasingly recognized for its role in neointima formation.
Purpose:
- To review the metallurgic characteristics of materials used in coronary stents.
- To summarize clinical and experimental data on the biocompatibility and restenosis impact of different stent alloys.
- To explore how stent material influences vessel wall injury, inflammation, and cell proliferation.
Summary:
- First-generation stents primarily used stainless steel, with less focus on material properties.
- Current research indicates that the metallic alloy of a coronary stent directly affects neointima formation and restenosis.
- Stent materials vary in mechanical and biocompatible properties, crucial for their impact on the vessel wall.
Impact:
- Understanding stent material properties is key to mitigating restenosis.
- This review provides insights into the biocompatibility and metallurgical aspects of coronary stents.
- Findings can guide the development of improved stent designs to reduce restenosis rates in coronary artery disease.
